Search
for
Sort by
Research 781–810 of 1000+
- Anti-Alopecia Activity of Alkaloids Group from Noni Fruit against Dihydrotestosterone-Induced Male Rabbits and Its Molecular Mechanism: In Vivo and In Silico Studies
- Antiandrogenic activity of Riboflavin 5′-phosphate (FMN) in 22Rv1 and LNCaP human prostate cancer cell lines
- Aldosterone- and cortisol-cosecreting adrenal adenoma, ovarian hyperthecosis and breast cancer
- Integrated evaluation of umbilical cord mesenchymal stromal cell-derived extracellular vesicles across skin-related cellular and zebrafish models
- An updated landscape of Female Pattern Hair Loss
- Androgenetic Alopecia in Polycystic Ovary Syndrome: A Cutaneous Marker of Systemic Metabo-inflammatory and Endocrine Dysfunction: A Narrative Review
- Minoxidil May be a Partial Agonist of Estrogen Receptor Alpha
- Identification of A p300–SP1–BRD4 Transcriptional Axis as a Key Driver of AR Hyperactivation in Polycystic Ovarian Syndrome
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Genetic Insights into Acne, Androgenetic Alopecia, and Alopecia Areata: Implications for Mechanisms and Precision Dermatology
- Subcutaneous injection of genetically engineered exosomes for androgenic alopecia treatment
- Updates in Treatment for Androgenetic Alopecia
- A Large Benign Adrenocortical Adenoma Cosecreting Testosterone and Cortisol
- The Pathogenesis and Treatment Progress of Androgenic Alopecia
- A review of hyperandrogenism state in polycystic ovarian syndrome
- Neuroendocrine, Neurotransmitter, and Gut Microbiota Imbalance Contributing to Potential Psychiatric Disorder Prevalence in PCOS
- Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes
- SnapshotDx Quiz: August 2019
- Co-editors’ Messages
- 63-Year-Old Female with Diffuse Thinning of the Hair
- The role of mutations on gene AR, in androgenetic alopecia syndrome
- Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis
- A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women
- Recomendations on non-pharmacological interventions in women with PCOS to reduce body weight and improve metabolic disorders [Zalecenia dotyczące postępowania niefarmakologicznego u kobiet z PCOS celem zmniejszenia masy ciała i poprawy zaburzeń metabolicznych]
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- Effect of body mass index (BMI) on phenotypic features of polycystic ovary syndrome (PCOS) in Singapore women: a prospective cross-sectional study
- Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial
- Male Equivalent Polycystic Ovarian Syndrome: Hormonal, Metabolic, and Clinical Aspects.
- Effects of hormonal treatment on dermatological outcome in transgender people: a multicentric prospective study (ENIGI)
- Dermatosis associated with menopause